Alternative medicine approvals based on pilot efficacy trials urged by consultant.
This article was originally published in The Tan Sheet
ALTERNATIVE MEDICINE PRODUCT APPROVAL BASED ON PILOT CLINICALS for efficacy and human safety trials was urged by Floyd Leaders, PhD, of The Leaders Group at a recent conference on alternative medicine in Arlington, Va. Leaders, who has served as a consultant to the National Institutes of Health's Office of Alternative Medicine, suggested that "FDA could grant marketing approval of an NDA for these products based on in-use human safety and pilot-level clinical trials for effectiveness."
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC